133 related articles for article (PubMed ID: 34304673)
21. Optimal timing to retrieve oocytes for fertility preservation in patients with acute myeloid leukemia: two cases of controlled ovarian stimulation using DuoStim with a literature review.
Sekiguchi M; Ito A; Fukuda Y; Yoneyama M; Furui M; Nakaoka K; Umemura N; Hayashi Y; Tamaki Y; Katagiri Y; Nakata M
Gynecol Endocrinol; 2023 Dec; 39(1):2217262. PubMed ID: 37271166
[TBL] [Abstract][Full Text] [Related]
22. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
[TBL] [Abstract][Full Text] [Related]
23. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
Fabris AM; Cruz M; Legidos V; Iglesias C; Muñoz M; García-Velasco JA
Reprod Sci; 2017 Aug; 24(8):1221-1225. PubMed ID: 28715965
[TBL] [Abstract][Full Text] [Related]
24. Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations.
von Wolff M; Bruckner T; Strowitzki T; Germeyer A
J Assist Reprod Genet; 2018 Sep; 35(9):1713-1719. PubMed ID: 29869766
[TBL] [Abstract][Full Text] [Related]
25. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
26. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
[TBL] [Abstract][Full Text] [Related]
27. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
28. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
29. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
[TBL] [Abstract][Full Text] [Related]
30. HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.
Haas J; Kedem A; Machtinger R; Dar S; Hourvitz A; Yerushalmi G; Orvieto R
J Ovarian Res; 2014 Apr; 7():35. PubMed ID: 24694069
[TBL] [Abstract][Full Text] [Related]
31. Random start controlled ovarian hyperstimulation for fertility preservation during incidental pregnancy: a case report of blastocyst vitrification from
Şükür YE; Özkavukçu S; İlhan FC; Şimşir C; Sönmezer M
Gynecol Endocrinol; 2019 Jul; 35(7):564-566. PubMed ID: 30798632
[TBL] [Abstract][Full Text] [Related]
32. GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials.
Hu KL; Wang S; Ye X; Zhang D; Hunt S
Reprod Biol Endocrinol; 2021 Jun; 19(1):78. PubMed ID: 34059045
[TBL] [Abstract][Full Text] [Related]
33. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
34. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
European Recombinant LH Study Group
J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
[TBL] [Abstract][Full Text] [Related]
35. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
[TBL] [Abstract][Full Text] [Related]
36. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population.
Manuel SL; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Pavone ME
J Assist Reprod Genet; 2020 Mar; 37(3):699-708. PubMed ID: 31828481
[TBL] [Abstract][Full Text] [Related]
37. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
Cai H; Shen H
Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608
[TBL] [Abstract][Full Text] [Related]
38. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
39. Which is the optimal timing for starting chemoprotection with gonadotropin-releasing hormone agonists after oocyte cryopreservation? Reflections on a critical case of ovarian hyperstimulation syndrome.
Marin L; Vitagliano A; Capobianco G; Dessole F; Ambrosini G; Andrisani A
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101815. PubMed ID: 32562778
[TBL] [Abstract][Full Text] [Related]
40. Flexible ovarian stimulation in a poor responder: a case report and literature review.
Xu B; Li Y
Reprod Biomed Online; 2013 Apr; 26(4):378-83. PubMed ID: 23497915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]